Clariant AG stock (CH0012142631): New CEO and turnaround focus after weak 2024 start

Specialty chemicals producer Clariant AG is entering a new phase of its turnaround story after a weak start to 2024 and a change at the top of the company. On May 15, 2024 Clariant reported lower first-quarter earnings as softer demand and negative currency effects weighed on results, while simultaneously confirming a new chief executive to drive its next strategy cycle, according to Clariant investor information as of 04/25/2024 and a management announcement published on May 15, 2024 via Reuters as of 05/15/2024.

As of: 09.06.2026

By the editorial team – specialized in equity coverage.

Clariant AG: core business model

Clariant AG is a Switzerland-based specialty chemicals company focusing on value-added products rather than bulk commodity chemicals. The group is structured around three main business units: Care Chemicals, Catalysts, and Adsorbents & Additives, each targeting applications where performance and innovation are key differentiators, according to Clariant’s company overview in its 2023 annual report published on March 1, 2024, as described by Clariant investor documents as of 03/01/2024.

In Care Chemicals, Clariant serves end-markets such as consumer care, crop solutions, and industrial applications with surfactants and functional ingredients designed to meet regulatory and sustainability requirements. These products often enjoy higher margins due to formulation complexity and tailored performance. The Catalysts unit supplies catalysts used in petrochemicals, syngas, and specialty chemical processes, where long-term customer relationships and high switching costs can support recurring revenue streams, according to product descriptions in Clariant’s segment reporting released with its full-year 2023 figures on March 1, 2024 and summarized by Reuters as of 03/01/2024.

The Adsorbents & Additives division provides materials used for purification, environmental applications, packaging, and polymer performance. These offerings benefit from technical specifications and customer qualification processes that can make demand more resilient than for base chemicals. Clariant’s strategy has been to focus on these specialties after divesting businesses such as pigments and masterbatches in recent years, with the company highlighting a more streamlined portfolio and a target to lift its EBITDA margin through the cycle, according to its strategy outline presented at an investor event in November 2023 and referenced by Clariant capital markets day materials as of 11/27/2023.

Main revenue and product drivers for Clariant AG

Clariant’s revenue is diversified across several end-markets, but the company is particularly exposed to consumer-related and industrial demand cycles through its Care Chemicals and Adsorbents & Additives units. In full-year 2023, Clariant reported sales of 4.377 billion Swiss francs and an EBITDA of 708 million Swiss francs, representing an EBITDA margin of about 16.2% for the year, according to the company’s annual results released on March 1, 2024 via Clariant investor information as of 03/01/2024.

Care Chemicals has historically been one of Clariant’s largest contributors to sales and earnings, supported by demand for personal care ingredients, crop solutions, and performance products used in a wide range of applications. This unit benefited from price increases in prior years but has also faced destocking phases when customers reduce inventories, which was an issue in parts of 2023 and into early 2024 as described in Clariant’s commentary on market conditions in its first-quarter 2024 report released on April 25, 2024, summarized by Reuters as of 04/25/2024.

The Catalysts unit can be more cyclical and project-driven, as large catalyst orders are linked to investment cycles in the chemicals and energy industries. However, Clariant has emphasized growth opportunities in catalysts for sustainable fuels and chemical recycling. Adsorbents & Additives, meanwhile, is tied to packaging, plastics, and environmental solutions, where regulatory pressure for more sustainable materials can drive product innovation. The company has been investing in R&D and selectively in capacity to support these areas, according to its 2023 R&D outline and sustainability report published alongside the annual report on March 1, 2024 and referenced by Clariant annual reporting as of 03/01/2024.

For U.S. investors, a key revenue driver is Clariant’s footprint in North America, where the company serves customers in consumer care, oil and gas, and industrial applications. Clariant does not break out North American sales as a separate segment in its main external reporting, but it highlights the region as one of its core growth markets and operates production and R&D sites in the United States serving local and multinational customers, according to its regional footprint overview updated in 2023 and available via Clariant locations information as of 10/30/2023.

Leadership change and 2024 earnings backdrop

The latest key development for Clariant has been a change in top leadership. On May 15, 2024 Clariant announced that Robert MacLeod, former chief executive of UK-based Johnson Matthey, would become its new CEO, succeeding Conrad Keijzer. The company said MacLeod would join the firm later in 2024, subject to customary approvals, bringing extensive experience in specialty chemicals and catalysts, according to a company statement cited by Reuters as of 05/15/2024.

The leadership change came against a backdrop of weaker earnings at the start of 2024. For the first quarter of 2024, Clariant reported sales of 1.041 billion Swiss francs, down from 1.275 billion Swiss francs in the same quarter a year earlier, and an adjusted EBITDA of 158 million Swiss francs versus 207 million Swiss francs a year before. The adjusted EBITDA margin fell to 15.2% from 16.2%, with the company citing soft demand and adverse foreign exchange effects, as disclosed in its Q1 2024 results release on April 25, 2024 and summarized by Reuters as of 04/25/2024.

Despite the slower start, Clariant confirmed its 2024 guidance at the time of its first-quarter release. The company said it still expected adjusted EBITDA for 2024 to increase to between 650 million and 700 million Swiss francs, up from 2023, supported by cost-saving measures and an expected normalization in demand later in the year. Management also reiterated its medium-term ambition to achieve an EBITDA margin between 19% and 21% and mid-single-digit to high-single-digit annual sales growth, according to its guidance commentary in the Q1 2024 presentation published on April 25, 2024 and available via Clariant Q1 2024 materials as of 04/25/2024.

To support profitability, Clariant has been implementing a performance improvement program targeting efficiency gains and cost reductions. By the end of 2023, the company said it had realized a significant portion of the planned savings and aimed to reach a run-rate of 170 million Swiss francs in cost savings by 2025, according to the performance program update in its full-year 2023 report released on March 1, 2024 and discussed in Reuters as of 03/01/2024.

Industry trends and competitive position

Clariant operates in the global specialty chemicals market, competing with peers such as BASF’s specialty divisions, Evonik, and Croda in various niches. The sector is influenced by trends including the shift to more sustainable and bio-based chemicals, stricter environmental regulations, and changing consumer preferences. These trends create both risks and opportunities, as companies must invest in innovation while managing portfolio complexity, as highlighted in industry reviews by sector analysts in 2023 referenced by Reuters as of 01/12/2023.

For Clariant, one strategic pillar is its focus on sustainability and circular economy solutions, such as catalysts for cleaner fuels and additives that enhance recyclability of plastics. The company has committed to science-based climate targets and aims to reduce greenhouse gas emissions across scopes, which could become a competitive differentiator in winning business from customers with their own decarbonization targets, according to its sustainability update published alongside the 2023 annual report on March 1, 2024 and described by Clariant sustainability reporting as of 03/01/2024.

However, the European chemicals industry has recently faced headwinds from high energy costs, slower industrial activity, and increased competition from regions with lower costs. Clariant’s presence in North America and Asia-Pacific offers geographic diversification, but it must navigate these industry-wide pressures while executing its portfolio strategy and cost program. Sector analysts have noted that normalization of energy prices and improvement in global industrial production could support a recovery in specialty chemicals demand, though the timing remains uncertain, as discussed in an overview of European chemicals published by a major financial news agency on January 12, 2023 and quoted by Reuters as of 01/12/2023.

Why Clariant AG matters for US investors

Although Clariant is listed on the SIX Swiss Exchange and reports in Swiss francs, its products and customer base are global, including a meaningful presence in the United States. For U.S.-based investors looking at the global specialty chemicals space, Clariant offers exposure to trends in consumer care ingredients, catalysts for cleaner processes, and advanced materials used in packaging and plastics, areas that intersect with North American and global industrial activity. Clariant highlights the U.S. as a key market for its oil and mining service-related chemistry as well as for consumer care applications, according to its regional business descriptions last updated in 2023 on the company’s site and accessed via Clariant locations information as of 10/30/2023.

U.S. investors considering international equities may also pay attention to Clariant’s governance structure and shareholder base. The company has anchor shareholders from Saudi Arabia’s chemicals giant SABIC and other investors, which can influence strategic decisions and long-term alignment, as previously reported by financial media in the context of earlier board discussions in 2018 and 2019 and referenced in a background article by Reuters as of 07/26/2018. Currency exposure is another consideration for U.S. investors, since the stock is denominated in Swiss francs and Clariant’s earnings come from multiple regions, creating potential translation effects when measured in U.S. dollars.

Over time, total shareholder return will depend on Clariant’s ability to execute its strategy under the new CEO, maintain or improve margins, and grow its portfolio in higher-value segments while navigating cyclical demand. Developments in U.S. industrial production, energy markets, and consumer spending may indirectly influence Clariant’s performance through its North American operations and global customer relationships. Investors tracking the specialty chemicals sector often compare Clariant’s valuation and earnings trajectory with both European and U.S.-listed peers to assess relative positioning, as indicated by cross-regional sector commentary in financial media throughout 2023 and 2024 such as reports compiled by Reuters as of 09/28/2023.

Conclusion

Clariant AG is working through a challenging phase marked by softer demand and currency headwinds, while simultaneously refreshing its top leadership and pushing ahead with a performance improvement program. The appointment of Robert MacLeod as incoming CEO in 2024 and the reaffirmation of 2024 guidance despite a weaker first quarter underscore management’s focus on delivering higher profitability and growth over the medium term. For U.S. investors, the stock represents an international specialty chemicals exposure with meaningful ties to North American and global industrial trends, but outcomes will depend on execution, industry conditions, and the pace at which the new strategy translates into improved earnings and cash flow.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.